1. Home
  2. DERM vs MAGN Comparison

DERM vs MAGN Comparison

Compare DERM & MAGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Journey Medical Corporation

DERM

Journey Medical Corporation

HOLD

Current Price

$4.95

Market Cap

267.4M

Sector

Health Care

ML Signal

HOLD

Logo Magnera Corporation

MAGN

Magnera Corporation

HOLD

Current Price

$9.00

Market Cap

316.5M

ML Signal

HOLD

Company Overview

Basic Information
Metric
DERM
MAGN
Founded
2014
1864
Country
United States
United States
Employees
N/A
8500
Industry
Biotechnology: Pharmaceutical Preparations
Paper
Sector
Health Care
Basic Materials
Exchange
Nasdaq
Nasdaq
Market Cap
267.4M
316.5M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
DERM
MAGN
Price
$4.95
$9.00
Analyst Decision
Strong Buy
Hold
Analyst Count
3
1
Target Price
$12.67
$12.00
AVG Volume (30 Days)
271.8K
515.7K
Earning Date
05-13-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
34.72
N/A
EPS
N/A
N/A
Revenue
$61,858,000.00
N/A
Revenue This Year
$66.12
$4.09
Revenue Next Year
$52.94
$2.34
P/E Ratio
N/A
N/A
Revenue Growth
10.20
N/A
52 Week Low
$4.31
$7.82
52 Week High
$9.56
$16.44

Technical Indicators

Market Signals
Indicator
DERM
MAGN
Relative Strength Index (RSI) 28.45 27.70
Support Level N/A $8.93
Resistance Level $8.05 $15.24
Average True Range (ATR) 0.50 0.45
MACD -0.22 0.03
Stochastic Oscillator 17.39 11.42

Price Performance

Historical Comparison
DERM
MAGN

About DERM Journey Medical Corporation

Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.

About MAGN Magnera Corporation

Magnera Corp is a supplier of a diverse portfolio of specialty materials comprised of organic and synthetic raw ingredients. The company markets its own products predominantly into stable, consumer-oriented end markets, including wipes, healthcare, adult incontinence, apparel, baby, feminine care, air filtration, and food and beverage, for disposable and durable applications. It also provides technical solutions in infrastructure markets. The company's operations are organized into two operating and reportable segments: Americas and Rest of World. It derives the majority of its revenue from the Americas, which manufactures products and components of personal care, including medical garments, wipes, dryer sheets, filtration, baby diapers and adult incontinence.

Share on Social Networks: